Yara stock remains supported by strong fertilizer earnings

Yara International ASA (NO0010208051) remains a closely watched fertilizer name after its latest reported revenue, earnings, and cash flow figures showed how sensitive the business is to prices, energy costs, and seasonal demand. The company has also continued to publish investor materials through its investor relations page.

Margin pressure and earnings

Yara reported 2025 revenue of EUR 13.1 billion, down from EUR 15.3 billion in 2024, while adjusted EBITDA fell to EUR 1.47 billion from EUR 2.29 billion a year earlier. Net income for 2025 was EUR 0.54 billion, compared with EUR 1.16 billion in 2024, showing how quickly fertilizer pricing can reshape profitability across one reporting year.

The scale of the decline matters for investors because Yara’s result base remains highly cyclical. A revenue drop of EUR 2.2 billion year on year is large enough to change the earnings picture even before operational details are considered.

Cash flow and capital discipline

In 2025, Yara generated free cash flow of EUR 0.76 billion and kept net debt at EUR 4.73 billion, which gives a more conservative lens than profit alone. The company also paid a dividend of NOK 5.00 per share for 2024, underlining that capital returns continue alongside heavy swings in profitability.

Those numbers help explain why the market often values Yara on cash generation and cycle timing rather than on a single quarter. A business with EUR 4.73 billion in net debt and EUR 0.76 billion in free cash flow needs steady operating performance to preserve flexibility through the cycle.

Revenue down 14%

Yara’s 2025 revenue decline of roughly 14.4% year on year from EUR 15.3 billion to EUR 13.1 billion gives a direct comparison that is more useful than a broad sector label. EBITDA fell by about 35.8% over the same period, from EUR 2.29 billion to EUR 1.47 billion, a gap that highlights the leverage in fertilizer margins when prices normalize.

For a stock like Yara, that combination of lower sales and a sharper drop in EBITDA is the key read-through. It suggests that margin recovery, not just volume growth, is likely to matter most when the next results arrive.

Fertilizer volumes and product mix

Yara’s core product base remains centered on nitrogen fertilizers, industrial nitrogen solutions, and crop nutrition products, with the business still tied to global agriculture demand and gas-linked input costs. That exposure explains why one year of earnings can look very different from the next even when the company keeps its industrial footprint unchanged.

For the product side, the important point is that the portfolio is built around recurring agricultural demand rather than one-off project sales. That makes operating discipline and plant utilization more important than narrative expansion when margins are under pressure.

Stock level to watch

Yara stock should be read against its latest published financial base, because the share price tends to react to EBITDA, debt, and cash flow more than to simple revenue growth. The company’s 2025 figures give investors a dated reference point: EUR 13.1 billion revenue, EUR 1.47 billion adjusted EBITDA, and EUR 4.73 billion net debt.

Those are the numbers that frame the next move in the shares, not a generic sector view. When the market re-prices Yara, it usually starts with margin recovery expectations and the durability of cash generation.

Yara through one product line

YaraVita and the wider crop nutrition range sit close to the company’s commercial identity because they connect the industrial base to farm demand. That link matters when the market assesses whether lower fertilizer prices are temporary or part of a longer normalization phase.

The product angle is useful because it shows how the company monetizes its industrial capacity across agriculture and nutrition rather than depending on a single end market. In practice, that is why the stock is often judged on utilization, pricing, and EBITDA conversion at the same time.

Stock backdrop

Yara stock is best understood as a cyclical industrial and agricultural equity with a dated 2025 revenue base of EUR 13.1 billion and adjusted EBITDA of EUR 1.47 billion. The company’s market story still runs through earnings quality, net debt, and the timing of fertilizer pricing rather than through a single headline event.

That makes the latest published numbers the clearest reference point for the shares as of 18 July 2026, even without a fresh corporate catalyst in the text.